Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

57 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes.
Lyra A, Krogius-Kurikka L, Nikkilä J, Malinen E, Kajander K, Kurikka K, Korpela R, Palva A. Lyra A, et al. Among authors: Kajander K. BMC Gastroenterol. 2010 Sep 19;10:110. doi: 10.1186/1471-230X-10-110. BMC Gastroenterol. 2010. PMID: 20849659 Free PMC article. Clinical Trial.
Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome.
Kajander K, Myllyluoma E, Kyrönpalo S, Rasmussen M, Sipponen P, Mattila I, Seppänen-Laakso T, Vapaatalo H, Oresic M, Korpela R. Kajander K, et al. World J Gastroenterol. 2009 Dec 28;15(48):6068-74. doi: 10.3748/wjg.15.6068. World J Gastroenterol. 2009. PMID: 20027679 Free PMC article.
Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.
Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, Mäkivuokko H, Kajander K, Palva A. Krogius-Kurikka L, et al. Among authors: Kajander K. BMC Gastroenterol. 2009 Dec 17;9:95. doi: 10.1186/1471-230X-9-95. BMC Gastroenterol. 2009. PMID: 20015409 Free PMC article.
In school-aged children a combination of galacto-oligosaccharides and Lactobacillus GG increases bifidobacteria more than Lactobacillus GG on its own.
Piirainen L, Kekkonen RA, Kajander K, Ahlroos T, Tynkkynen S, Nevala R, Korpela R. Piirainen L, et al. Among authors: Kajander K. Ann Nutr Metab. 2008;52(3):204-8. doi: 10.1159/000138124. Epub 2008 Jun 11. Ann Nutr Metab. 2008. PMID: 18544974 Clinical Trial.
Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R. Kajander K, et al. Aliment Pharmacol Ther. 2008 Jan 1;27(1):48-57. doi: 10.1111/j.1365-2036.2007.03542.x. Epub 2007 Oct 5. Aliment Pharmacol Ther. 2008. PMID: 17919270 Free article. Clinical Trial.
57 results
Jump to page
Feedback